Filing Details
- Accession Number:
- 0000899243-18-020533
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-24 19:15:51
- Reporting Period:
- 2018-07-23
- Accepted Time:
- 2018-07-24 19:15:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1434418 | Constellation Pharmaceuticals Inc | CNST | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1192595 | I Robert Tepper | C/O Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200 Cambridge MA 02142 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-07-23 | 2,705,334 | $0.00 | 2,716,384 | No | 4 | C | Indirect | By Funds |
Common Stock | Acquisiton | 2018-07-23 | 266,667 | $15.00 | 2,983,051 | No | 4 | P | Indirect | By Funds |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Funds |
No | 4 | P | Indirect | By Funds |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2018-07-23 | 11,000,000 | $0.00 | 999,180 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2018-07-23 | 10,650,000 | $0.00 | 967,389 | $0.00 |
Common Stock | Series D Preferred Stock | Disposition | 2018-07-23 | 1,086,411 | $0.00 | 98,683 | $0.00 |
Common Stock | Series E Preferred Stock | Disposition | 2018-07-23 | 2,285,640 | $0.00 | 266,934 | $0.00 |
Common Stock | Series E-1 Preferred Stock | Disposition | 2018-07-23 | 3,107,930 | $0.00 | 282,308 | $0.00 |
Common Stock | Series F Preferred Stock | Disposition | 2018-07-23 | 1,000,000 | $0.00 | 90,840 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- On July 23, 2018, the Series A, Series B, Series D, Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B, Series C, Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
- These securities are directly held by Third Rock Ventures, L.P. ("TRV"). The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC"). Dr. Tepper is an individual manager of TRV GP LLC. Dr. Tepper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.